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<ABSTRACT>
Quantitative Evaluation of Vascularity on Power Doppler US may 
not Identify Malignancy of the Thyroid
Jung Hyun Yoon
Department of Medicine 
The Graduate School, Yonsei University 
(Directed by Professor Jin Young Kwak)
Purpose: To evaluate the usefulness of vascular index (VI) and in 
predicting thyroid malignancy.
Materials & Methods: This retrospective study was approved by 
our institutional review board, and informed consent was waived. A 
total of 1,309 thyroid nodules in 1,257 patients (mean age, 50.2 
years; range, 18-83 years) were included. Clinical characteristics of 
the patients and grayscale US were reviewed. Vascularity pattern 
on Doppler US was classified as none, peripheral, and intranodular. 
VI was measured with a quantification software from Power 
Doppler images obtained prior to biopsy. Diagnostic performances 
of grayscale US alone, US combined with vascularity patterns or 
VI was calculated and compared. 
Results: Of the 1,309 thyroid nodules, 927 (70.8%) were benign 
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and 382 (29.2%) were malignancy. Mean value of VI was 
significantly higher in benign compared to malignancy, 19.1±19.3% 
to 15.4±17.9% (P<0.001). When cutoff of VI was set at 9.6% in 
discriminating between benign and malignant thyroid nodules, 
sensitivity of US combined to vascularity pattern (91.4%) or VI 
(95.8%) was significantly higher than US alone (89.0%, P<0.001), 
with lower specificity (62.1% and 28.2% to 74.3%, respectively, 
P<0.001). Area under the receiver operating characteristics curve 
(Az) of grayscale US was significantly higher than US combined to 
vascularity pattern or VI, 0.82 to 0.77 and 0.70, respectively (all 
P<0.001).
Conclusion: Quantified vascularity values were higher in benign 
than malignant nodules. Neither vascularity patterns nor VI are not 
predictive of malignancy, and does not improve the diagnostic 
performances of US in the predicting thyroid malignancy.

Key words : thyroid, neoplasm, ultrasound, Doppler, vascularity
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Quantitative Evaluation of Vascularity on Power Doppler US may 
not Identify Malignancy of the Thyroid
Jung Hyun Yoon
Department of Medicine 
The Graduate School, Yonsei University 
(Directed by Professor Jin Young Kwak)
I. INTRODUCTION
With the widely spread usage of thyroid ultrasonography (US), 
many asymptomatic, ‘incidental’ thyroid nodules have been detected, 
reports showing that nearly 4-67% of the otherwise healthy population 
are have nodular disease of the thyroid.1-4 Despite the vast number of 
thyroid nodules detected annually, most are confirmed as benign and only 
about 5-6.5% of these prove to be malignant lesions.3,5,6 Many diagnostic 
methods have been applied in effort to sort out the malignant from 
benign lesions, and ultrasonography (US) due to its simplicity, 
accessibility, and safety, is the most popularly used imaging modality in 
the differential diagnosis of thyroid nodules. Thyroid nodules have 
variable appearances visualized on gray-scale US images, and several US 
features have been acknowledged to be highly associated with 
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malignancy, such as solid composition, irregular or microlobulated 
margins, hypoechogenicity or markedly hypoechogenicity, presence of 
micro- or macrocalcifications, ‘taller-than-wide’ shape, and absence of 
halo  sign,1-5 but many US features overlap and are seen in both benign 
and malignant nodules.
As with development of technology, Color Doppler US along 
with Power Doppler US has made identifying vascular pattern within 
thyroid nodules possible, and many studies have focused on using 
Doppler features on US in acquiring additional information for 
differentiation of various thyroid nodules.1,3,6-9 Results of several studies 
showed that the presence of intranodular vascularity may be useful in 
predicting malignancy and recommending US-FNA,1,3,4,6 but controversy 
remains in whether Doppler US provides reliable information, mostly 
since vascularity patterns or spectral parameters overlap between benign 
and malignant nodules.3,8-10 Also, as with other grayscale US features, 
qualitative vascularity pattern is subjected to intra- or interobserver 
variability as described in several reports.11,12 In a recent study including 
large sample data, the presence of vascularity was more seen in benign 
thyroid nodules than malignancy,13 which is in conflict with the general 
concept that malignant masses show increased vascularity. Based on these 
results, we hypothesized that quantitative measurement of vascularity of 
the thyroid nodule may be more objective and informative in predicting 
malignancy. In a recent study, quantitative thyroid vascular index (VI) 
was used in predicting thyroid malignancy,14 indicating the potential for 
using  vascular indices in differential diagnosis of thyroid nodules. We 
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used Qlab quantification software on Power Doppler US in measuring VI 
describing the amount of color within a region-of-interest(ROI).15,16
Therefore, the purpose of this study was to evaluate whether 
quantitative evaluation of vascularity visualized on Power Doppler US can 
be used in predicting malignancy among thyroid nodules. 
II. MATERIALS AND METHODS
This study is of retrospective design and has been approved by 
the Institutional Review Board (IRB) of Severance Hospital, Seoul, Korea. 
Neither patient approval nor informed consent was required for review of 
medical records or images. Informed consent was signed and obtained 
from all patients before US-FNA or surgery prior to procedures. 
 
1. Patients
From December 2010 to July 2011, 3,342 patients had undergone 
US-FNA at our institution, a referral center. Of these patients, 1,648 
thyroid nodules in 1,585 patients had real-time Power Doppler US images 
recorded during US examinations prior to US-FNA procedures. Of these 
nodules, 1) nodules with inadequate cytology which had not been 
followed with either US-FNA or US examinations (n=227), 2) nodules 
with atypia of undetermined significance/follicular lesion of undetermined 
significance (AUS/FLUS) (n=84), follicular neoplasm (FN) or suspicious 
for follicular neoplasm (n=9) or suspicious for malignancy (n=19) 
cytology which had not been followed with US-FNA or surgery was 
excluded. Finally, 1,309 thyroid nodules in 1,257 patients (mean age, 
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50.1±12.1 years; range, 18-83 years) fulfilling the following inclusion 
criteria were included in this study: 1) thyroid nodules with diagnosis 
confirmed by surgery after inadequate, AUS/FLUS, FN or suspicious for 
FN, or suspicious for malignancy cytology, or 2) nodules with definitive 
diagnosis of benign or malignancy on US-FNA (Fig 1). Among the 1,257 
patients, 192 (15.3%) were men (mean age, 50.3±12.1 years; range, 23-76 
years) and 1,065 (84.7%) were women (mean age, 50.0±12.0 years; 
range, 18-83 years). Mean size of the 1,309 thyroid nodules was 
15.1±10.3 mm; range, 5-66 mm).
Figure 1. Diagram showing the inclusion criteria of this study 
US-FNA: US-guided fine needle aspiration, F/U: follow-up, AUS/FLUS: atypia of 
undetermined significance/follicular lesion of undetermined significance, FN: 
follicular neoplasm
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2. US Examinations & Vascularity 
US examination of the thyroid was performed using a 5- to 
12-MHz linear array transducer (iU22; Philips Medical Systems, Bothell, 
WA, USA). Real-time US was performed by one of the 12 
board-certified radiologists (4 faculties and 8 fellows) with 1-15 years of 
experience in thyroid imaging. 
US features of each thyroid nodule were prospectively recorded 
in radiologic reports and our institutional database by the radiologist who 
was involved in US examinations and subsequent US-FNA. For 
assessment of US features, each thyroid nodule was described according 
to the following categories: tumor composition, echogenicity, margin, 
calcifications and shape.8 Tumor composition was classified as solid or 
mixed (mixture of solid and cystic contents), ≥50% solid, <50% solid. 
Echogenicity was classified as hyper- to isoechogic, hypoechogenicity 
compared to the adjacent thyroid parenchyma, or markedly 
hypoechogenicity compared to the adjacent strap muscle. Margin was 
classified as well-defined or non-circumscribed, i.e., microlobulated, or 
ill-defined margins. Calcification was classified as no calcifications, 
macrocalcifications including eggshell calcifications, or microcalcifications 
or mixed calcifications. Shape was classified as parallel or non-parallel 
(greater in anteroposterior dimension than the transverse dimension). Of 
these US features, markedly hypoechogenicity, non-circumscribed margins, 
microcalcifications or mixed calcifications, and non-parallel shape were 
considered as malignant features, based on published criteria.8 Final 
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assessment was categorized as ‘probably benign’, when none of the 
suspicious US features described above were present, and ‘suspicious 
malignant’, when one or more of the malignant features were present in 
a thyroid nodule. 
Vascularity was evaluated on Doppler US images performed 
during US examinations, and was classified into 3 patterns: no 
vascularity, defined as absence of Doppler signals at the periphery or 
within the thyroid nodule, peripheral vascularity, defined as the presence 
of Doppler signals at the periphery of the nodule, and intranodular 
vascularity, defined as the presence of Doppler signals within the thyroid 
nodule with or without the presence of vascular flow at the periphery of 
the nodule (Fig 2).15 
 (a)
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 (b)
 (c)
Figure 2. Power Doppler US images showing representative cases of vascularity 
pattern: (a) no vascularity, (b) peripheral vascularity, (c) intranodular vascularity, 
regardless of the presence of peripheral vascularity. 
To obtain data regarding VI in color Doppler images, Doppler US 
images of the nodule targeted for biopsy was recorded and placed in a 
separate workstation for data analysis. Quantification of the vascularity in 
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the thyroid nodules was obtained using Qlab 7.0 quantification software 
(Philips Medical Systems, Andover, MA, USA). Qlab enables color flow 
quantification using a ROI for color loops, providing quantitative 
information regarding vascularity and the blood flow measured within a 
ROI using pixel counting technique. VI represents the amount of color 
detected within the ROI, calculated as the color percentage within the 
volume of interest [VI of ROI = (number of color pixels)/(total pixels – 
background pixels)].17,18 One radiologist reviewed the US images using 
Qlab software and drew the ROIs along the tumor margin. VI values 
were automatically calculated by the Qlab software, which was displayed 
as a VI graph as an absolute time to VI curve. Among the various VI 
values, the peak VI value was obtained and used in analysis (Fig 3). 
Figure 3. Quantification of vascularity as vascular index (VI) using Power 
Doppler US via Qlab software. The region-of-interest (ROI) was set including 
the borders of the mass, and the software calculated the VI within the selected 
ROI automatically, representing the VI graph according to time (time to VI 
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curve, arrow). The peak VI value was obtained and used as the representative 
value.
3. US-guided Fine Needle Aspiration (US-FNA)
US-FNA was performed at the thyroid nodule showing suspicious 
US features or at the largest mass when none of the multiple thyroid 
nodules observed showed any suspicious US features. After US 
examination, US-FNA was performed using freehand technique by the 
same radiologist who had performed US examinations, using 23-gauge 
needles attached to a 2-mL disposable plastic syringe without an 
aspirator. Each nodule was aspirated at least twice. Cytology slides were 
reviewed by one of five experienced cytopathologists specializing in 
thyroid pathology. During the study period, cytologic reports from 
US-FNA of the thyroid was based on the 6-categories from the Bethesda 
System for Reporting Thyroid Cytopathology at our institution.17
 
4. Data and Statistical Analysis
Histopathologic results based on surgery or US-FNA was 
regarded as standard reference. Independent two-sample t-test was used in 
comparison of continuous variables such as age and tumor size between 
benign and malignant groups. Chi-square test was used in comparison of 
categorical variables between the two groups. Univariate and multivariate 
logistic regression analysis was used in evaluating the independent factors 
among US features and vascularity in predicting malignancy. Multivariate 
logistic regression analysis was performed twice, first, including grayscale 
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US features and qualitative vascularity patterns, and second, including 
grayscale US features and VI. Pearson correlation coefficient was used to 
assess the correlation between vascularity pattern and VI. 
Optimal cutoff value for VI in differentiating between benign and 
malignant thyroid nodules was calculated using Youden index. Diagnostic 
performances including sensitivity, specificity, positive predictive value 
(PPV), negative predictive value (NPV), and accuracy was calculated 
using the calculated cutoff value for VI and compared among the three 
criteria using generalized estimating equation (GEE) method. Area under 
the receiver operating characteristics curve was obtained and compared. 
Statistical analyses were performed using SAS statistical software (SAS 
Institute, version 9.2, Cary, NC, USA). Statistical significance was 
determined as a P value of less than 0.05.
III. RESULTS
Of the 1,309 thyroid nodules included, 927 (70.8%) were benign 
and 382 (29.2%) were malignancy. Mean age of the patients was 
significantly younger in those with malignant nodules than benign, 
47.7±12.3 years to 51.1±11.7 years, respectively (P<0.001). No significant 
differences were seen in malignant nodules according to patient gender, 
women 29.0% to men 30.3% (P=0.693). Mean size of the malignant 
thyroid nodules were significantly smaller than that of benign ones, 
10.3±6.7 mm to 17.0±10.9 mm (P<0.001). Of the 1,309 thyroid nodules, 
564 (43.1%) nodules measured less than or equal to 10 mm in diameter, 
and the remaining 745 (56.9%) measured larger than 10 mm. Among the 
- 13 -
US  Features Pathology P
Benign   
(n=927)
Malignancy   
(n=382)
Composition   < 0.001
Solid 582 (62.8) 346 (90.6)  
Mixed,   ≥50% solid 290 (31.3) 31 (8.1)  
Mixed,   <50% solid 55 (5.9) 5 (1.3)  
Echogenicity   < 0.001
Hyper- to   isoechoic 498 (53.7) 24 (6.3)  
Hypoechoic 416 (44.9) 326 (85.3)  
Markedly   hypoechoic 13 (1.4) 32 (8.4)  
Margin   < 0.001
Circumscribed 724 (78.1) 99 (25.9)  
Microlobulated 
or ill-defined
203 (21.9) 283 (74.1)  
Calcifications   < 0.001
No calcifications 708 (76.4) 165 (43.2)  
Macrocalcifications 112 (12.1) 39 (10.2)  
Micro- or mixed 107 (11.5) 178 (46.6)  
Shape   < 0.001
Parallel 806 (87.0) 170 (44.5)  
Non-parallel 121 (13.0) 212 (55.5)  
1,309 thyroid nodules, 347 had been confirmed by surgery as the 
following: papillary thyroid carcinoma (PTC, n=303), follicular variant of 
papillary thyroid carcinoma (n=23), adenomatous hyperplasia (n=14), 
medullary carcinoma (n=1), follicular carcinoma (n=1), follicular adenoma 
(n=4), and lymphocytic thyroiditis (n=1).
Table 1 summarizes the comparison grayscale US features and 
Power Doppler US features between benign and malignant thyroid 
nodules. 
Table 1. Comparison of grayscale US features and Power Doppler US features 
in benign and malignant thyroid nodules
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US  Features Pathology P
Benign   
(n=927)
Malignancy   
(n=382)
Final assessment   < 0.001
Probably benign 689 (74.3) 42 (11.0)  
Suspicious malignant 238 (25.7) 340 (89.0)  
Vascularity pattern   < 0.001
No vascularity 160 (17.3) 121 (31.7)  
Peripheral vascularity 271 (29.2) 144 (37.7)  
Intranodular vascularity 496 (53.5) 117 (30.6)  
Vascularity Index (VI) 19.1±19.3% 15.4±17.9% 0.001
Solid tumor composition, hypo- or markedly hypoechogenicity, 
non-circumscribed margins (microlobulated or ill-defined), micro- or mixed 
calcifications, non-parallel shape, and suspicious malignant final 
assessments were more frequently seen in malignant thyroid nodules.
Multivariate logistic regression analysis show that hypoechoic or 
markedly hypoechoic features, non-circumscribed margins, micro- or 
mixed calcifications, non-parallel shape were independent factors 
predictive of malignancy (all P<0.001, Table 2).
- 15 -
Variables Univariate  Multivariate*  Multivariate†  
All nodules
(n=1,309)
OR (95% CI) P OR (95% CI) P OR (95% CI) P
Composition       
Solid 6.540 (0.438, 3.157) < 0.001 1.052 (0.328, 3.375) 0.932 0.962 (0.302, 3.070) 0.948
Mixed, ≥50% solid 1.176 (2.593, 16.494) 0.748 1.899 (0.628, 5.738) 0.256 1.801 (0.598, 5.428) 0.296
Mixed, <50% solid - - - - - -
Echogenicity       
Hyper- to isoechoic - - - - - -
Hypoechoic 16.261 (10.530, 25.110) < 0.001 5.344 (3.292, 8.675) < 0.001 5.555 (3.436, 8.979) < 0.001
Markedly hypoechoic 51.077 (23.798, 109.627) < 0.001 9.612 (4.074, 22.677) < 0.001 9.967 (4.247, 23.391) < 0.001
Margin       
Circumscribed - - - - - -
Non-circumscribed 10.195 (7.730, 13.446) < 0.001 2.575 (1.823, 3.638) < 0.001 2.656 (1.884, 3.744) < 0.001
Calcifications       
No calcifications - - - - - -
Macrocalcifications 1.494 (1.000, 2.233) 0.050 0.966 (0.608, 1.534) 0.883 0.983 (0.620, 1.559) 0.942
Micro- or mixed 7.138 (5.322, 9.574) < 0.001 3.131 (2.218, 4.422) < 0.001 3.026 (2.149, 4.261) < 0.001
Shape       
Parallel - - - - - -
Non-parallel 8.307 (6.291, 10.968) < 0.001 2.582 (1.841, 3.621) < 0.001 2.652 (1.896, 3.709) <0.001
Vascularity pattern       
Table 2. Univariate and multivariate logistic regression analysis for factors predicting malignancy among the 1,309 thyroid 
nodules
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Variables Univariate  Multivariate*  Multivariate†  
All nodules
(n=1,309)
OR (95% CI) P OR (95% CI) P OR (95% CI) P
No vascularity - - - - - -
Peripheral vascularity 0.703 (0.515, 0.959) 0.026 0.745 (0.506, 1.096) 0.135 - -
Intranodular
vascularity
0.312 (0.982, 0.996) < 0.001 0.689 (0.463, 1.026) 0.067 - -
Vascularity index 
(VI)
0.989 (0.982, 0.996) 0.001 - - 0.998 (0.990, 1.007) 0.709
Nodules ≤ 10mm (n=564)
Composition       
Solid 2.027 (0.616, 6.671) 0.245 0.721 (0.154, 3.377) 0.678 0.705 (0.150, 3.301) 0.657
Mixed, ≥50% solid 0.450 (0.119, 1.703) 0.240 0.335 (0.064, 1.763) 0.335 0.318 (0.061, 1.672) 0.176
Mixed, <50% solid - - - - - -
Echogenicity       
Hyper- to isoechoic - - - - - -
Hypoechoic 8.153 (4.442, 14.965) < 0.001 3.496 (1.747, 6.994) < 0.001 3.527 (1.771, 7.025) < 0.001
Markedly hypoechoic 17.000 (6.136, 47.102) < 0.001 5.965 (1.930, 18.435) 0.002 5.961 (1.940, 18.310) 0.002
Margin       
Circumscribed - - - - - -
Non-circumscribed 5.119 (3.495, 7.496) < 0.001 2.064 (1.307, 3.259) 0.002 2.077 (1.314, 3.283) 0.002
Calcifications       
No calcifications - - - - - -
   
Macrocalcifications
0.954 (0.538, 1.693) 0.872 0.880 (0.471, 1.645) 0.690 0.879 (0.471, 1.642) 0.686
Micro- or mixed 2.953 (1.991, 4.378) < 0.001 2.207 (1.424, 3.420) < 0.001 2.174 (1.405, 3.364) < 0.001
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Variables Univariate  Multivariate*  Multivariate†  
All nodules
(n=1,309)
OR (95% CI) P OR (95% CI) P OR (95% CI) P
Shape       
Parallel - - - - - -
Non-parallel 4.882   (3.404, 7.002) <   
0.001
2.515 (1.665, 3.801) < 0.001 2.528 (1.675, 3.815) 2.528
Vascularity pattern       
No vascularity - - - - - -
Peripheral vascularity 0.756 (0.512, 1.116) 0.159 0.815 (0.522, 1.271) 0.367 - -
Intranodular 
vascularity
0.509 (0.328, 0.791) 0.003 0.849 (0.508, 1.420) 0.533 - -
Vascularity index 
(VI)
0.991 (0.982, 0.999) 0.032 - - 0.999 (0.989, 1.009) 0.879
Nodules > 10mm (n=745)
Composition       
Solid 16.588 (2.262, 121.617) 0.006 4.204 (0.527, 33.548) 0.175 3.824 (0.482, 30.335) 0.204
Mixed, ≥50% solid 3.800 (0.496, 29.097) 0.199 2.949 (0.353, 24.617) 0.318 2.585 (0.313, 21.353) 0.378
Mixed, <50% solid - -   - -
Echogenicity       
Hyper- to isoechoic - - - - - -
Hypoechoic 19.553 (10.295, 37.138) < 0.001 7.018 (3.442, 14.312) < 0.001 7.218 (3.551, 14.674) < 0.001
Markedly hypoechoic 107.455 
(33.145, 348.359)
< 0.001 12.279 
(3.075, 49.028)
< 0.001 12.917 (3.297, 50.609) < 0.001
Margin       
Circumscribed - - - - - -
Non-circumscribed 15.287 (9.917, 23.565) < 0.001 3.193 (1.828, 5.576) < 0.001 3.216 (1.845, 5.607) < 0.001
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Variables Univariate  Multivariate*  Multivariate†  
All nodules
(n=1,309)
OR (95% CI) P OR (95% CI) P OR (95% CI) P
Calcifications       
No calcifications - - - - - -
Macrocalcifications 3.134 (1.699, 5.782) < 0.001 0.999 (0.476, 2.097) 0.998 1.116 (0.545, 2.283) 0.765
Micro- or mixed 21.099 (13.032, 34.161) < 0.001 4.538 (2.507, 8.215) < 0.001 4.411 (2.457, 7.919) < 0.001
Shape       
Parallel - - - - - -
Non-parallel 11.012 (6.858, 17.681) < 0.001 2.601 (1.393, 4.857) 0.003 2.578 (1.384, 4.801) 0.003
Vascularity pattern       
No vascularity - - - - - -
Peripheral vascularity 0.810 (0.465, 1.411) 0.457 0.583 (0.271, 1.253) 0.167 - -
Intranodular
vascularity
0.408 (0.243, 0.686) 0.001 0.501 (0.243, 1.032) 0.501 - -
Vascularity index 
(VI)
0.984 (0.972, 0.996) 0.008 - - 0.995 (0.981, 1.010) 0.516
OR: odds ratio, 95% CI: 95% confidence intervals
*: vascularity pattern as confounding factor, †: VI as confounding factor
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US features Benign Malignancy P
All lesions (n=1,309)
No vascularity 160 (17.3) 121 (31.7) < 0.001
Presence of vascularity 767 (82.7) 261 (68.3)  
Peripheral vascularity 271 (29.2) 144 (37.7)  
Intranodular vascularity 496 (53.5) 117 (30.6)  
Vascularity index 19.1±19.3% 15.4±17.9% 0.001
≤ 9.6% 381 (41.1) 204 (53.4) < 0.001
> 9.6% 546 (58.9) 178 (46.6)  
Lesions ≤ 10mm (n=564)
No vascularity 93 (29.0) 94 (38.7) 0.011
Presence of vascularity 228 (71.0) 149 (61.3)  
Peripheral vascularity 127 (39.5) 97 (39.9)  
Intranodular vascularity 101 (31.5) 52 (21.4)  
Vascularity index 19.8±21.0% 16.1±18.4% 0.028
Among vascularity patterns and VI, no vascularity or smaller VI values 
were factors predictive of malignancy in univariate analysis. When 
subdividing the thyroid nodules according to size, i.e., measuring less 
than or equal to 10mm and larger than 10mm, no vascularity or smaller 
VI values were factors predictive of malignancy in univariate analysis in 
both groups. However, multivariate analysis showed that qualitative 
vascularity patterns or quantitative VI values were not predictive of 
malignancy in all 1,309 thyroid nodules, in nodules measuring less than 
or equal to 10mm, and in nodules larger than 10mm (Table 2). 
Table 3 summarizes the Power Doppler US features in the 1,309 
thyroid nodules according to size. In all 1,309 thyroid nodules, no 
vascularity was more frequently seen in malignancy among vascularity 
pattern (31.7% to 17.3%, P<0.001). 
Table 3. Power Doppler US features in the 1,309 thyroid nodules according to 
size
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US features Benign Malignancy P
≤ 9.6% 143 (44.5) 129 (53.1) 0.044
> 9.6% 178 (55.5) 114 (46.9)  
Lesions > 10mm (n=745)
No vascularity 67 (11.1) 27 (19.4) < 0.001
Presence of vascularity 539 (89.0) 112 (70.6)  
Peripheral vascularity 144 (23.8) 47 (33.8)  
Intranodular vascularity 395 (65.2) 65 (46.8)  
Vascularity index 18.7±18.3% 14.2±16.9% 0.007
≤ 9.6% 239 (39.4) 76 (54.7) 0.001
> 9.6% 367 (60.6) 63 (45.3)  
In the presence of vascularity, intranodular vascularity was more 
frequently seen in benign lesions. The same results were seen in nodules 
measuring less than or equal to 10 mm and larger than 10mm. In all 
nodules, mean value of VI was significantly smaller in malignancy 
compared to benign, 15.4±17.9% to 19.1±19.3% (P< 0.001). When the 
cutoff for VI was set at 9.6%, VI of less than 9.6% was more 
frequently seen in malignancy (P< 0.001). Mean value of VI was 
significantly smaller in malignancy compared to benign in nodules less 
than 10 mm or larger than 10 mm, 16.1±18.4% to 19.8±21.0% in 
nodules less than 10 mm (P= 0.028) and 14.2±16.9% to 18.7±18.3% (P= 
0.007) (Fig 4). VI of less than 9.6% was more frequently seen in 
malignancy among nodules less than 10 mm (53.4% to 41.1%) or larger 
than 10 mm (53.1% to 44.5%, P= 0.044 and 0.001, respectively).
Vascularity pattern showed moderate but significant correlation to 
VI, r=0.344 (P< 0.001, Fig 5). 
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Figure 4. Decile frequency plot of vascular index in the 1,309 thyroid nodules. 
Higher VI values are observed in benign than malignant nodules. 
Figure 5. Box plot showing the correlation between vascularity pattern and VI
Diagnostic performances of grayscale US in the diagnosis of 
thyroid nodules in the 1,309 thyroid nodules are as follows: sensitivity 
89.0%, specificity 74.3%, positive predictive value (PPV) 58.8%, and 
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negative predictive value (NPV) 94.3% (Table 4). When vascularity 
pattern and VI was combined to grayscale US, sensitivity was 
significantly increased (89.0% to 91.4% and 95.8%) while specificity 
(74.3% to 62.1% and 28.2%) and PPV (58.8% to 49.9% and 35.5%) was 
significantly decreased. Area under the receiver operating characteristics 
curve  (Az) value of grayscale US was 0.821, which was significantly 
decreased when combined to vascularity pattern (0.766, P< 0.001) or VI 
(0.702, P< 0.001).
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Sensitivity P* Specificity P* PPV P* NPV P* AUC
(95% CI)
P*
All lesions (n= ,309)
US 89.0 
(340/382)
 74.3 
(689/927)
 58.8 
(340/578)
 94.3 
(689/731)
 0.821 
(0.804-0.836)
 
Vascularity 
pattern
34.0 
(130/382)
 80.4 
(745/927)
 41.7 
(130/312)
 74.7 
(745/997)
 0.565
(0.551-0.602)
 
Vascularity 
index†
53.7 
(205/382)
 58.8 
(545/927)
 34.9 
(205/587)
 75.5 
(545/722)
 0.562 
(0.527-0.590)
 
US+vascularity 
pattern
91.4 
(349/382)
<0.001 62.1 
(576/927)
<0.001 49.9 
(349/700)
<0.001 94.6 
(576/609)
0.993 0.766 
(0.748-0.792)
<0.001
US+vascularity 
index†
95.8 
(366/382)
0.005 28.2 
(261/927)
<0.001 35.5 
(366/1032)
<0.001 94.2 
(261/277)
0.486 0.702 
(0.683-0.724)
<0.001
  0.070‡  <0.001‡  <0.001‡  0.652‡  <0.001‡
Nodules ≤ 10mm (n=564)
US 93.8 
(228/243)
 52.0 
(167/321)
 59.7 
(228/382)
 91.8 
(167/182)
 0.729 
(0.698-0.761)
 
Vascularity 
pattern
40.3 
(98/243)
 67.9 
(218/321)
 48.8 
(98/201)
 60.1 
(218/363)
 0.541
(0.501-0.581)
 
Vascularity 
index†
53.1 
(129/243)
 55.5 
(178/321)
 47.4 
(129/272)
 61.0 
(178/321)
 0.543 
(0.501-0.584)
 
US+vascularity 
pattern
95.1 
(231/243)
0.082 32.7 
(105/321)
<0.001 51.7 
(231/447)
<0.001 89.7 
(105/117)
0.090 0.639
(0.610-0.668)
<0.001
Table 4. Diagnostic performances of grayscale US and US combined with vascularity pattern or VI obtained from Power 
Doppler US images
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Sensitivity P* Specificity P* PPV P* NPV P* AUC
(95% CI)
P*
US+vascularity 
index†
95.1 
(231/243)
0.082 36.8 
(105/308)
<0.001 53.2 
(231/434)
<0.001 89.7 
(105/117)
0.370 0.659 
(0.629-0.688)
<0.001
  1.000‡  0.041‡  0.055‡  0.582‡  <0.001‡
Nodules > 10mm (n=745)
US 80.6 
(112/139)
 86.1 
(522/606)
 57.1 
(112/196)
 95.1 
(522/549)
 0.833 
(0.798-0.869)
 
Vascularity 
pattern
23.0 
(32/139)
 87.0 
(527/606)
 28.8 
(32/139)
 83.1 
(527/634)
 0.550 
(0.512-0.585)
 
Vascularity 
index†
54.7 
(76/139)
 60.6 
(367/606)
 24.1 
(76/315)
 85.3 
(367/430)
 0.576 
(0.530-0.622)
 
US+vascularity 
pattern
89.9 
(125/139)
<0.001 53.1 
(322/606)
<0.001 30.6 
(125/409)
<0.001 95.8
(322/336)
0.376 0.715 
(0.683-0.747)
<0.001
US+vascularity 
index†
84.8 
(118/139)
0.028 75.6 
(458/606)
<0.001 44.4 
(118/266)
<0.001 95.6 
(458/479)
0.301 0.802 
(0.768-0.837)
0.003
  0.018‡  <0.001‡  <0.001‡  0.766‡  <0.001‡
AUC: area under the receiver operating characteristics curve, CI: confidence interval
*: compared to values of grayscale US
†: cutoff level set at 9.6%
‡: US+vascularity index values compared to US+vascularity pattern
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IV. DISCUSSION
In comparing diagnostic performances of grayscale US alone to 
US combined to vascularity pattern or VI, sensitivity was significantly 
increased with tradeoff for decreased specificity and PPV in our study. 
Also, Az value of grayscale US was the highest (Az, 0.821), showing 
significantly decreased values when US was combined to vascularity 
pattern (Az, 0.766) or VI (Az, 0.702). These results show that as with 
the qualitative vascularity pattern, quantitative VIs do not improve the 
performances of grayscale US in the differential diagnosis of thyroid 
nodules. In addition, multivariate analysis including grayscale US features 
and vascularity pattern or VI shows that no vascularity, intranodular 
vascularity, or VI are not significant predictors for malignancy in thyroid 
nodules. As suggested in recent studies,14,18 vascularity detected on Power 
Doppler US, either qualitative or quantitative, has potential in providing 
additional tumor characteristics to grayscale US features, but has limited 
value when used alone or in combination with grayscale US as predictors 
for malignancy.
Grayscale US alone has been proven and accepted as a superior 
diagnostic tool in accurately selecting patients who are in need for 
invasive diagnostic procedures such as US-FNA,2,12,19 but unfortunately no 
specific US criteria has been reported to effectively predict malignancy 
among thyroid nodules. Up to the present, quite a few studies have 
applied Doppler US to grayscale US features in predicting thyroid 
malignancy,3,5,7,8,12,15,20 but controversy still remains in whether assessment 
of vascularity in thyroid nodules is helpful in distinguishing between 
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benign and malignant thyroid masses. Most of the previous studies have 
used qualitative assessment in describing vascularity, i.e., no vascularity, 
peripheral vascularity, or intranodular vascularity, analysis based on static 
images which are subjectively selected.14 Subjectivity in image selection 
and assessment of vascularity pattern is the main cause for this 
unreliability, therefore, demanding a more objective and quantitative 
means in measuring tumor vascularity. To overcome this limitation, 
several recent studies have used the novel quantitative thyroid vascularity 
indices (VIs) in determining the performances of quantitative vascularity 
parameters in predicting thyroid malignancy.13,14 However, in these studies 
a limited number of thyroid nodules have been included for evaluation. 
In this study, we included a large population of thyroid nodules to 
validate the results of the previous studies, and to investigate the 
usefulness of quantitative vascularity assessment using Power Doppler US 
in the differential diagnosis of thyroid nodules.
In our study, no vascularity was more frequently seen in 
malignancy among vascularity pattern (31.7% to 17.3%, P<0.001). In the 
presence of vascularity, intranodular vascularity was more frequently seen 
in benign lesions. These results remain the same when thyroid nodules 
are subdivided according to size, that is, lesions measuring less than 10 
mm or larger than 10 mm. These results are somewhat in conflict to the 
results of prior studies claiming that intranodular vascularity is  a feature 
predictive of thyroid malignancy,1,3,4,20-24  but consistent or comparable to 
the results of other studies.13,25-27  When considering our results along 
with the heterogeneous results of prior studies, we think that vascularity 
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pattern from Doppler US has limited value in predicting malignancy in 
thyroid nodules. In addition, as our results show significant overlap exists 
in each vascularity pattern among benign and malignant lesions, 
approximately 19.1% of nodules showing intranodular vascularity was 
malignant, which further supports the unreliability of vascularity pattern 
of Doppler US.
Mean VI of benign nodules compared to malignant ones had 
significantly higher values, 19.1±19.3% to 15.4±17.9% (P<0.001). These 
results are in conflict with the concept that malignant masses are more 
hypervascular than benign ones, which may be explained by two reasons. 
First, benign tumors such as follicular adenoma have a higher degree of 
vascularity compared to malignant masses such as PTC or follicular 
carcinoma pathologically,28 and lesser vessel compliance or stenosis in 
benign tumors may have contributed to the increased vascularity measured 
on Doppler US. In contrast, microvasculatures derived from 
neoangiogenesis process of malignant masses are mostly composed of 
vessels of very small diameters, and in spite of the high sensitivity of 
Power Doppler US in detecting vascular flow, and flow within these 
microvessels may have not been detected. Second, mean size of 
malignant masses were significantly smaller than benign ones, 10.3±6.7 
mm to 17.0±10.9 mm (P< 0.001), which may had effect on these results. 
Nodules smaller than 2.5 cm were more frequently avascular than larger 
ones in one study,20 and the absence of vascularization mainly correlates 
to tumor size than its benign or malignant character.29 A recent study 
also has reported similar results in that benign nodules showed higher 
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quantitative VI values,14 and further studies with adjustment in tumor size 
is needed for validation of these results.
There are several limitations to this study. First, only 347 
(26.7%) nodules have undergone surgery while the remaining 73.3% had 
been diagnosed based on cytologic results. False-negative or false-positive 
cytology results may have occurred, which may have effect on our 
results. Second, quantitative vascularity index in our study has been 
measured in a single 2-dimensional image plane, which has its limitations 
in representing volumetric vascular structure. Further studies using 
3-dimensional US images are anticipated to validate our results. Third, 12 
radiologists were involved in US assessment and recording Power 
Doppler US images. Interobserver variability in categorization and 
assessment of grayscale images may have affected our results. Also, 
Power Doppler US features differ according to technical settings might 
affect the amount of color signals within a ROI set for measurements.14,16 
To minimize this effect, VI measurements were applied on images 
obtained from the same machine using the technical settings. Last, of the 
347 surgically-confirmed thyroid nodules, 326 (93.9%) were diagnosed as 
PTC or its variants. The majority of malignant masses included in our 
study represents features of PTC, and although PTC consists of 
approximately 80% of thyroid cancers,30 vascularity features of follicular 
neoplasm may have shown different results that we had not been able to 
consider in this study.
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V. CONCLUSION
In conclusion, quantified vascularity values were higher in benign 
than malignant nodules. Quantitative vascularity index is not predictive of 
malignancy, and does not improve the diagnostic performances of US in 
the predicting thyroid malignancy.
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Abstract (in Korean)
갑상선의 악성 결절을 예측하는데 있어 
도플러 초음파를 이용한 혈관 분포의 정량 분석의 유용성
<지도교수 곽 진 영>
연세대학교 대학원 의학과
윤 정 현 
목적: 갑상선의 악성 결절을 예측하는데 있어 혈관 지표 (vascular 
index, VI) 의 유용성에 대해서 알아보고자 한다. 
대상 및 방법: 본 연구는 2010년 12월부터 2011년 7월 까지, 본원에
서 세침흡인 검사 혹은 수술을 시행받은 1,257명의 환자 (평균 연령: 
50.2세, 연령 범위: 18-83세) 에서 1,309예의 갑상선 결절을 대상으
로 하였다. 초음파 영상소견 및 환자의 임상적 특징을 기록하여 분석
에 사용하였다. 혈관 패턴(vascularity pattern)은 신호 없음, 주변
부 혈관 분포, 혹은 중심부 혈관 분포로 나누었다. VI는 세침 검사 
이전에 시행된 도플러 초음파 영상에서 정량 분석 프로그램을 이용하
여 계산하였다. 초음파 영상 단독, 초음파 영상에 혈관 패턴 혹은 VI
를 이용한 각각의 경우에 대해서 진단 결과를 비교 분석하였다. 
결과: 총 1,309예의 갑상선 결절 중 927 (70.8%)은 양성, 382 
(29.2%) 예는 악성으로 최종 진단되었다. VI의 평균값은 양성 결절 
(19.1±19.3%)에서 악성 결절 (15.4±17.9%)보다 유의하게 높았다   
(P<0.001). 양성과 악성 결절을 감별하는데 있어 VI의 기준값을 9.6%
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로 설정하였을 때, 초음파에 혈관 패턴 (91.4%) 혹은 VI (95.8%)를 
같이 이용한 진단의 민감도는 초음파 단독 (89.0%) 에 비해서 유의하
게 높았고 (P<0.001), 특이도는 초음파에 도플러 수치를 병합한 경우 
(62.1% 와 28.2%)가 초음파 단독 (74.3%)에 비해서 유의하게 낮았다 
(P<0.001). Area under the receiver operating characteristics 
curve (Az) 분석에서 초음파 단독의 결과는 (0.82) 초음파에 혈관 패
턴 (0.77) 혹은 VI (0.70)을 병합한 것의 결과보다 유의하게 높았다 
(P<0.001).
결론: 갑상선 결절의 정량 분석 수치는 양성 결절에서 악성 결절보다 
유의하게 높은 값을 보였다. 혈관 패턴이나 VI와 같은 도플러 변수들
은 갑상선의 악성 결절을 예측하는데 있어 도움이 되지 않는다. 

핵심되는 말 : 갑상선, 결절, 초음파, 도플러, 혈관분포
